Paul R. Ortiz de Montellano, PhD

Paul R. Ortiz de Montellano, PhD

Professor, Departments of Pharmaceutical Chemistry and Pharmacology, UCSF

Phone: (415) 476-2903 (office), 502-4728 (asst)
Box 2280, UCSF
San Francisco, CA 94143-2280

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Additional Websites


Mass. Institute of Technology (Cambridge, MA), B.S., 1964, Chemistry
Harvard University (Cambridge, MA), M.A., 1966, Chemistry
Harvard University (Cambridge, MA), Ph.D., 1968, Bioorganic Chemistry
Eidg. Tech. Hochschule (Zurich, Switzerland), Postdoc, 1968-1969, Bioorganic Chemistry

Professional Experience

  • 1969-1971
    Group Leader, Syntex Research Laboratories
  • 1972-1980
    Assistant/Associate Professor, University of California, San Francisco
  • 1980-present
    Professor of Chemistry, Pharmaceutical Chemistry, and Pharmacology, University of California, San Francisco
  • 1982-1994
    Vice Chairman, Department of Pharmaceutical Chemistry
  • 1978-1979
    Professeur Associe, Institut de Chimie, Universite Louis Pasteur, Strasbourg, France
  • 1985-1986
    Honorary Fellow, Department of Biochemistry, University College, London
  • 1993-1994
    Professeur Rhone Poulenc, Universite René Descartes (Paris V), Paris, France
  • 2000-2001
    Visiting Academic, Department of Biochemistry & Molec. Biol., University College, London

Honors & Awards

  • 1960-1964
    McDermott Scholar (MIT)
  • 1965-1968
    NIH Predoctoral Fellow (Harvard)
  • 1968-1969
    NATO Postdoctoral Fellow
  • 1988
    Alfred P. Sloan Foundation Research Science
  • 1989
    John Moffat Lecturer, University of British Columbia
  • 1989-1999
    NIH MERIT Award
  • 1989, 1996, 1997
    UCSF Long Foundation Award for Excellence in Teaching
  • 1991
    King/Chavez/Parks Visiting Professor, University of Michigan
  • 1991
    Distinguished University Lecturer, University of Utah
  • 1994
    Wellcome Visiting Professor, Washington State University
  • 1994
    B. B. Brodie Award in Drug Metabolism of the American Society of Pharmacology and Experimental Therapeutics
  • 1998
    Robert A. Welch Foundation Lecturer, University of Texas Campuses
  • 2000
    Chauncey Leake Lecturer, University of Texas Medical Branch Galveston
  • 2001
    Karcher Lecturer, University of Oklahoma

Selected Publications

  1. Conner KP, Cruce AA, Krzyaniak MD, Schimpf AM, Frank DJ, Ortiz de Montellano P, Atkins WM, Bowman MK. Drug Modulation of Water-Heme Interactions in Low-Spin P450 Complexes of CYP2C9d and CYP125A1. Biochemistry. 2015 Feb 10; 54(5):1198-207.
    View on PubMed
  2. Frank DJ, Madrona Y, Ortiz de Montellano PR. Cholesterol ester oxidation by mycobacterial cytochrome p450. J Biol Chem. 2014 Oct 31; 289(44):30417-25.
    View on PubMed
  3. Varfaj F, Zulkifli SN, Park HG, Challinor VL, De Voss JJ, Ortiz de Montellano PR. Carbon-carbon bond cleavage in activation of the prodrug nabumetone. Drug Metab Dispos. 2014 May; 42(5):828-38.
    View on PubMed
  4. Conner KP, Schimpf AM, Cruce AA, McLean KJ, Munro AW, Frank DJ, Krzyaniak MD, Ortiz de Montellano P, Bowman MK, Atkins WM. Strength of axial water ligation in substrate-free cytochrome P450s is isoform dependent. Biochemistry. 2014 Mar 11; 53(9):1428-34.
    View on PubMed
  5. Nishida CR, Everett S, Ortiz de Montellano PR. Specificity determinants of CYP1B1 estradiol hydroxylation. Mol Pharmacol. 2013 Sep; 84(3):451-8.
    View on PubMed
  6. García-Fernández E, Frank DJ, Galán B, Kells PM, Podust LM, García JL, Ortiz de Montellano PR. A highly conserved mycobacterial cholesterol catabolic pathway. Environ Microbiol. 2013 Aug; 15(8):2342-59.
    View on PubMed
  7. Ortiz de Montellano PR. Cytochrome P450-activated prodrugs. Future Med Chem. 2013 Feb; 5(2):213-28.
    View on PubMed
  8. Meitzler JL, Hinde S, Bánfi B, Nauseef WM, Ortiz de Montellano PR. Conserved cysteine residues provide a protein-protein interaction surface in dual oxidase (DUOX) proteins. J Biol Chem. 2013 Mar 8; 288(10):7147-57.
    View on PubMed
  9. Aicart-Ramos C, Valhondo Falcón M, Ortiz de Montellano PR, Rodriguez-Crespo I. Covalent attachment of heme to the protein moiety in an insect E75 nitric oxide sensor. Biochemistry. 2012 Sep 18; 51(37):7403-16.
    View on PubMed
  10. Varfaj F, Lampe JN, Ortiz de Montellano PR. Role of cysteine residues in heme binding to human heme oxygenase-2 elucidated by two-dimensional NMR spectroscopy. J Biol Chem. 2012 Oct 12; 287(42):35181-91.
    View on PubMed
  11. Johnston JB, Singh AA, Clary AA, Chen CK, Hayes PY, Chow S, De Voss JJ, Ortiz de Montellano PR. Substrate analog studies of the ?-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1. Bioorg Med Chem. 2012 Jul 1; 20(13):4064-81.
    View on PubMed
  12. Sivaramakrishnan S, Ouellet H, Matsumura H, Guan S, Moënne-Loccoz P, Burlingame AL, Ortiz de Montellano PR. Proximal ligand electron donation and reactivity of the cytochrome P450 ferric-peroxo anion. J Am Chem Soc. 2012 Apr 18; 134(15):6673-84.
    View on PubMed
  13. Vos MH, Bouzhir-Sima L, Lambry JC, Luo H, Eaton-Rye JJ, Ioanoviciu A, Ortiz de Montellano PR, Liebl U. Ultrafast ligand dynamics in the heme-based GAF sensor domains of the histidine kinases DosS and DosT from Mycobacterium tuberculosis. Biochemistry. 2012 Jan 10; 51(1):159-66.
    View on PubMed
  14. Meitzler JL, Ortiz de Montellano PR. Structural stability and heme binding potential of the truncated human dual oxidase 2 (DUOX2) peroxidase domain. Arch Biochem Biophys. 2011 Aug 15; 512(2):197-203.
    View on PubMed
  15. Sivaramakrishnan S, Ouellet H, Du J, McLean KJ, Medzihradszky KF, Dawson JH, Munro AW, Ortiz de Montellano PR. A novel intermediate in the reaction of seleno CYP119 with m-chloroperbenzoic acid. Biochemistry. 2011 Apr 12; 50(14):3014-24.
    View on PubMed
  16. Yukl ET, Ioanoviciu A, Sivaramakrishnan S, Nakano MM, Ortiz de Montellano PR, Moënne-Loccoz P. Nitric oxide dioxygenation reaction in DevS and the initial response to nitric oxide in Mycobacterium tuberculosis. Biochemistry. 2011 Feb 15; 50(6):1023-8.
    View on PubMed
  17. Ouellet H, Kells PM, Ortiz de Montellano PR, Podust LM. Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1. Bioorg Med Chem Lett. 2011 Jan 1; 21(1):332-7.
    View on PubMed
  18. Ortiz de Montellano PR, Nelson SD. Rearrangement reactions catalyzed by cytochrome P450s. Arch Biochem Biophys. 2011 Mar 1; 507(1):95-110.
    View on PubMed
  19. Meitzler JL, Brandman R, Ortiz de Montellano PR. Perturbed heme binding is responsible for the blistering phenotype associated with mutations in the Caenorhabditis elegans dual oxidase 1 (DUOX1) peroxidase domain. J Biol Chem. 2010 Dec 24; 285(52):40991-1000.
    View on PubMed
  20. Nishida CR, Ortiz de Montellano PR. Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases. Chem Biol Interact. 2011 Jun 30; 192(1-2):21-5.
    View on PubMed

Go to UCSF Profiles, powered by CTSI